linkedin

Press Releases

News Brief

Samsung Biologics participates in CPHI Worldwide 2022

[??2]%20CPHI%20????????%20??.png

Samsung Biologics is attending CPHI Worldwide 2022 in Frankfurt, Germany from November 1 to 3, hosting one of the largest booths to cater client meetings and showcase its capabilities and business growth.

 

The company’s new marketing message - “Accelerating Excellence” - will be featured for the first time at the event, reflecting Samsung Biologics’ commitment to innovative speed, uncompromising quality, and tailored solutions. 

 

Samsung Biologics will also be participating in two speaking sessions at CPHI this year. Kevin Sharp VP, Head of Global Sales Strategic Operations, will be sharing his insights on key considerations in choosing a CDMO partner on November 1, and James Choi EVP, Chief Information & Marketing Officer, on the importance of partnering with CDMO companies for a sustainable future on November 2.

 

To get in touch or to find out more about the speaking sessions, visit here.


[??2]%20CPHI%20????????%20??.png

Samsung Biologics is attending CPHI Worldwide 2022 in Frankfurt, Germany from November 1 to 3, hosting one of the largest booths to cater client meetings and showcase its capabilities and business growth.

 

The company’s new marketing message - “Accelerating Excellence” - will be featured for the first time at the event, reflecting Samsung Biologics’ commitment to innovative speed, uncompromising quality, and tailored solutions. 

 

Samsung Biologics will also be participating in two speaking sessions at CPHI this year. Kevin Sharp VP, Head of Global Sales Strategic Operations, will be sharing his insights on key considerations in choosing a CDMO partner on November 1, and James Choi EVP, Chief Information & Marketing Officer, on the importance of partnering with CDMO companies for a sustainable future on November 2.

 

To get in touch or to find out more about the speaking sessions, visit here.


SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Subscribe to our newsletter to download.
*If you have already subscribed, enter your email.

뉴스레터 구독 서비스 유무 확인
Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION

Copyright Samsung Biologics. All rights reserved